Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
168.00    3.25 (1.97%)
Bid:
158.00
Ask:
162.00
Spread: 4.00 (2.532%)
Market Cap: £1.44b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Hutchmed News

AIM WINNERS & LOSERS: Celebrus revenue to fall short of guidance
22 Apr 2025

AIM WINNERS & LOSERS: Celebrus revenue to fall short of guidance

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

LONDON MARKET OPEN: FTSE 100 opens green as gold reaches USD3,500 mark
22 Apr 2025

LONDON MARKET OPEN: FTSE 100 opens green as gold reaches USD3,500 mark

(Alliance News) - London's FTSE 100 opened higher on Tuesday following the long Easter weekend, as the gold price rallies in response to a weakening U...

Hutchmed enrols patients for phase two savolitinib trial
22 Apr 2025

Hutchmed enrols patients for phase two savolitinib trial

(Sharecast News) - Hutchmed China announced on Tuesday that it has completed patient enrollment for the registration phase of its phase two clinical t...

Hutchmed China completes enrolment for gastric cancer drug trial
22 Apr 2025

Hutchmed China completes enrolment for gastric cancer drug trial

(Alliance News) - Hutchmed China Ltd on Tuesday said it has completed patient enrolment for a phase II registration trial of savolitinib, targeting ga...

LONDON BRIEFING: DCC to sell Healthcare arm, Ricardo "well-positioned"
22 Apr 2025

LONDON BRIEFING: DCC to sell Healthcare arm, Ricardo "well-positioned"

(Alliance News) - London's FTSE 100 was called higher on Tuesday following the long Easter weekend as the gold price reaches a new record high, while ...

IN BRIEF: Hutchmed China's Tazverik conditionally approved in China
21 Mar 2025

IN BRIEF: Hutchmed China's Tazverik conditionally approved in China

Hutchmed China Ltd - Hong Kong-based biopharmaceutical firm - The new drug application for Tazverik has been granted conditional approval by the Natio...